The authors of this study emphasize the effectiveness of collectively funded public insurances as opposed to genetic information regulation within the private insurance sector. Genetics has provided tools to determine individuals’ risk of future disease, which is of key interest for insurance companies in determining insurance premiums; but persons with high enough risk may remain uninsured. For this reason, genetic information has been regulated. But, regulation may not be the solution, according to the authors, and they call for the resumption of social insurance, a key element of the welfare state.
![[PDF] Genes and Insurance: Ethical, Legal and Economic Issues Alasdair Maclean](https://digzon.com/wp-content/uploads/2024/04/8075247c9f4b6e2929c042715ca095ea-d.jpg)
![[PDF] Textbook of Stroke Medicine Michael Brainin MD, Wolf-Dieter Heiss MD](https://digzon.com/wp-content/uploads/2024/04/183bdb3a999b8dae2b714c2d08331e3f-d.jpg)
![[PDF] Pharmacogenetics of Breast Cancer: Towards the Individualization of Therapy (Translational Medicine) Leyland-Jones Brian](https://digzon.com/wp-content/uploads/2024/04/18a5f14719f2db034fea6681550c8ddb-d.jpg)
![[PDF] Plasmas at High Temperature and Density: Applications and Implications of Laser-Plasma Interaction (Update in Intensive Care and Emergency Medicine) Heinrich Hora](https://digzon.com/wp-content/uploads/2024/04/17992cc75f8f2bde5d0218263d423c56-d.jpg)
![[PDF] Parkinson's Disease: Methods & Protocols (Methods in Molecular Medicine) Maral Mouradian](https://digzon.com/wp-content/uploads/2024/04/17da01ab3d3e6f6f879bc58a177c06d6-d.jpg)
Reviews
There are no reviews yet.